A new series of titanocene dichloride derivatives bearing cyclic alkylammonium groups: Assessment of their cytotoxic properties

Journal of Organometallic Chemistry

Volumn 692, Issue 16, 2007, Pages 3508-3518

  Potter, Gregory D ^a   Baird, Michael C ^a   Cole, Susan P C ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

Anticancer drugs; Metallocenes; Titanocene dichloride

Indexed keywords

CELLS; COMPLEXATION; CYTOTOXICITY; ORGANOMETALLICS; SOLUBILITY; SYNTHESIS (CHEMICAL); TITANIUM COMPOUNDS; TUMORS;

ANTICANCER DRUGS; CYCLIC ALKYLAMMONIUM GROUPS; LUNG CANCER CELL LINES; TITANOCENE DICHLORIDE;

DERIVATIVES;

EID: 34250869512     PISSN: 0022328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jorganchem.2007.04.024     Document Type: Article

References (39)

1. Rosenberg B., Van Camp L., Trosko J.E., and Mansour V.H. Nature (London) 222 (1969) 385
2. Wheate N.J., and Collins J.G. Coord. Chem. Rev. 241 (2003) 133
3. Pérez J.M., Alonso C., and Fuertes M.A. Chem. Rev. 103 (2003) 645
4. Takahara P.M., Frederick C.A., and Lippard S.J. J. Am. Chem. Soc. 118 (1996) 12309
5. Wong E., and Giandomenico C.M. Chem. Rev. 99 (1999) 2451
6. Köpf-Maier P., and Köpf H. Struct. Bond. 70 (1988) 103
7. Köpf-Maier P., and Köpf H. Chem. Rev. 87 (1987) 1137
8. Harding M.M., and Mokdsi G. Curr. Med. Chem. 7 (2000) 1289
9. Kröger N., Kleeberg U.R., Mross K., Edler L., Saß G., and Hossfeld D.K. Onkologie 23 (2000) 60
10. Lümmen G., Sperling H., Luboldt G., Otto T., and Rübben H. Cancer Chemother. Pharmacol. 42 (1998) 415
11. Sadler P.J., and Guo Z. Angew. Chem. Int. Ed. 38 (1999) 1512
12. Sadler P.J., Guo M., and Guo Z. J. Biol. Inorg. Chem. 6 (2001) 698
13. Zhang Z., Yang P., Guo M., and Wang H. J. Inorg. Biochem. 63 (1996) 183
14. Mokdsi G., and Harding M.M. J. Inorg. Biochem. 83 (2001) 205
15. Toney J.H., and Marks T.J. J. Am. Chem. Soc. 107 (1985) 947
16. Mokdsi G., and Harding M.M. J. Organomet. Chem. 565 (1998) 29
17. Boyles J.R., Baird M.C., Campling B.G., and Jain N. J. Inorg. Biochem. 84 (2001) 195
18. B.W. Müller, R. Müller, S. Lucks, W. Mohr, US Patent 5296 (1994) 237.
19. Meyer R., Brink S., van Rensburg C.E.J., Jooné G.K., Görls H., and Lotz S. J. Organomet. Chem. 690 (2005) 117
20. Lu C.-S., Zou Y., Xie J.L., Ni Z.P., Zhu H.-Z., Meng Q.-J., and Yao Y.-G. Chem. Pharm. Bull. 51 (2003) 864
21. Ravera M., Cassino C., Monti E., Gariboldi M., and Osella D. J. Inorg. Biochem. 99 (2005) 2264
22. Tacke M., Allen L.T., Cuffe L., Gallagher W.M., Lou Y., Mendoza O., Müller-Bunz H., Rehmann F.-J.K., and Sweeney N.J. J. Organomet. Chem. 689 (2004) 2242
23. Sweeney N.J., Mendoza O., Müller-Bunz H., Pampillón C., Rehmann F.-J.K., Strohfeldt K., and Tacke M. J. Organomet. Chem. 690 (2005) 4537
24. Kelter G., Sweeney N.J., Strohfeldt K., Fiebig H.-H., and Tacke M. Anti-cancer Drugs 16 (2005) 1091
25. Rehmann F.-J.K., Cuffe L.P., Mendoza O., Rai D.K., Sweeney N., Strohfeldt K., Gallagher W.M., and Tacke M. Appl. Organomet. Chem. 19 (2005) 293
26. O'Connor K., Gill C., Tacke M., Rehmann F.-J.K., Strohfeld K., Sweeney N.J., Fitzpatrick J.M., and Watson R.W.G. Apoptosis 11 (2006) 1205
27. Pampillón C., Sweeney N.J., Strohfeld K., and Tacke M. J. Organomet. Chem. 692 (2007) 2153
28. Hogan M., Claffey J., Pampillón C., Watson R.W.G., and Tacke M. Organometallics 26 (2007) 2501
29. Gansäuer A., Franke D., Lauterbach T., and Nieger M. J. Am. Chem. Soc. 127 (2005) 11622
30. Causey P.W., Baird M.C., and Cole S.P.C. Organometallics 23 (2004) 4486
31. Potter G.D., Baird M.C., Chan M., and Cole S.P.C. Inorg. Chem. Commun. 9 (2006) 1114
32. McGowan M.A.D., and McGowan P.C. Inorg. Chem. Commun. 3 (2000) 337
33. Bradley S., Corradi M.M., Camm K.D., Furtado S.J., McGowan P.C., Mumtaz R., and Thornton-Pett M. J. Organomet. Chem. 656 (2002) 49
34. McGowan P.C., Allen O.R., Croll L., Gott A.L., and Knox R.J. Organometallics 23 (2004) 288
35. shelxtl NT: Crystal Structure Analysis Package, version 5.10; Bruker AXS Inc.: Madison, WI, 1999.
36. Campling B.G., Pym J., Baker H.M., Cole S.P.C., and Lam Y.M. Br. J. Cancer 63 (1991) 75
37. Mosmann T.J. Immun. Methods 65 (1983) 55
38. Cole S.P.C. Cancer Chemother. Pharmacol. 17 (1986) 259
39. Cole S.P.C. Cancer Chemother. Pharmacol. 26 (1990) 250